ES2178154T3 - Proceso de preparacion de formas solidas de dosificacion farmaceutica. - Google Patents
Proceso de preparacion de formas solidas de dosificacion farmaceutica.Info
- Publication number
- ES2178154T3 ES2178154T3 ES98904265T ES98904265T ES2178154T3 ES 2178154 T3 ES2178154 T3 ES 2178154T3 ES 98904265 T ES98904265 T ES 98904265T ES 98904265 T ES98904265 T ES 98904265T ES 2178154 T3 ES2178154 T3 ES 2178154T3
- Authority
- ES
- Spain
- Prior art keywords
- lipid
- active substance
- pharmaceutically active
- carrier
- preparation process
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La invención se refiere a un procedimiento de preparación de una forma galénica, oral y de desintegración rápida de una sustancia activa en el plano farmacéutico y que tiene un sabor muy desagradable. Dicho procedimiento comprende las etapas que consisten (i) en formar en un solvente, una solución o una suspensión de un excipiente soluble o dispersable en agua, de una carga y de dicha sustancia activa en el plano farmacéutico, que tiene un sabor muy desagradable y asociada a un lípido, estando la relación poderla de dicha sustancia y del lípido comprendida entre 1:1 y 1:10, estando la relación poderla del excipiente y del lípido comprendida entre 5:1 y 1:15, (ii) en formar unidades individuales de la suspensión o de la solución; y (iii) en extraer el solvente de estas unidades en condiciones que permiten la formación de dosis unitarias que comprenden una red del excipiente/carga que contiene una dosis de la sustancia activa en el plano farmacéutico asociado l lípido. La invención se refiere también a formas galénicas, orales, sólidas y de desintegración rápida preparadas gracias a tal procedimiento.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9702799.9A GB9702799D0 (en) | 1997-02-12 | 1997-02-12 | Process for preparing solid pharmaceutical dosage forms |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2178154T3 true ES2178154T3 (es) | 2002-12-16 |
Family
ID=10807446
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES98904265T Expired - Lifetime ES2178154T3 (es) | 1997-02-12 | 1998-02-12 | Proceso de preparacion de formas solidas de dosificacion farmaceutica. |
Country Status (13)
Country | Link |
---|---|
US (1) | US6156339A (es) |
EP (1) | EP0973506B1 (es) |
JP (1) | JP4763105B2 (es) |
AT (1) | ATE219664T1 (es) |
AU (1) | AU6221298A (es) |
BR (1) | BR9808641B1 (es) |
CA (1) | CA2278785C (es) |
DE (1) | DE69806236T2 (es) |
DK (1) | DK0973506T3 (es) |
ES (1) | ES2178154T3 (es) |
GB (1) | GB9702799D0 (es) |
PT (1) | PT973506E (es) |
WO (1) | WO1998035656A1 (es) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19853737C2 (de) * | 1998-11-21 | 2003-03-06 | Lohmann Therapie Syst Lts | Verfahren zum Spenden von flächigen Gebilden |
IT1315252B1 (it) * | 1999-10-21 | 2003-02-03 | Truffini & Regge Farmaceutici | Compresse gastroresistenti ad uso alimentare o dietetico ottenutemediante grassi miscelati alla massa |
US6589955B2 (en) | 2001-06-20 | 2003-07-08 | Bristol-Myers Squibb Company | Pediatric formulation of gatifloxacin |
GB0208742D0 (en) | 2002-04-17 | 2002-05-29 | Bradford Particle Design Ltd | Particulate materials |
US20040029843A1 (en) * | 2002-06-20 | 2004-02-12 | Orapharma, Inc. | Rapidly disintegrating formulations for treating or preventing mucositis |
US20040001885A1 (en) * | 2002-06-27 | 2004-01-01 | Unchalee Kositprapa | Rapidly disintegrating antihistamine formulation |
US6962006B2 (en) * | 2002-12-19 | 2005-11-08 | Acusphere, Inc. | Methods and apparatus for making particles using spray dryer and in-line jet mill |
US20040156894A1 (en) * | 2003-02-07 | 2004-08-12 | Grother Leon Paul | Use of edible acids in fast-dispersing pharmaceutical solid dosage forms |
US20040224024A1 (en) * | 2003-04-23 | 2004-11-11 | Massachusetts Institute Of Technology | Controlled drug release formulations containing polyion complexes |
KR20060015587A (ko) | 2003-05-08 | 2006-02-17 | 넥타 쎄라퓨틱스 유케이 리미티드 | 미립물 |
JP2007507548A (ja) * | 2003-10-07 | 2007-03-29 | アンドルックス ファーマスーティカルズ リミテッド ライアビリティ カンパニー | 速崩壊型製剤 |
WO2005046707A1 (en) | 2003-11-10 | 2005-05-26 | Fein Seymour H | Pharmaceutical compositions including low dosages of desmopressin |
DE20321887U1 (de) | 2003-11-10 | 2012-01-20 | Allergan, Inc. | Arzneimittel umfassend niedrige Dosierungen von Desmopressin |
US7811604B1 (en) | 2005-11-14 | 2010-10-12 | Barr Laboratories, Inc. | Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same |
AR061485A1 (es) * | 2006-06-15 | 2008-08-27 | Serenex Inc | Composiciones estabilizadas de tetraciclina |
US8889184B2 (en) * | 2006-09-07 | 2014-11-18 | Losan Pharma Gmbh | Particulate form of a pharmaceutical composition which is easy to swallow |
EP2120875B1 (en) | 2007-02-11 | 2018-07-11 | Map Pharmaceuticals Inc. | Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profile |
WO2011022737A2 (en) * | 2009-08-17 | 2011-02-24 | Waxtabs (Pty) Ltd | Tablet manufacture |
WO2011026080A1 (en) | 2009-08-31 | 2011-03-03 | Wilmington Pharmaceuticals, Llc | Fast disintegrating compositions of meloxicam, processes for preparation, and use to treat arthritis and/or pain |
FR2950807B1 (fr) * | 2009-10-06 | 2012-02-03 | Lvmh Rech | Composition cosmetique contenant des liposomes encapsules dans un compose oxazolidin-2-one |
CN110337290A (zh) | 2016-12-31 | 2019-10-15 | 比奥克斯塞尔医疗股份有限公司 | 舌下右旋美托咪啶用于治疗激越的用途 |
CN114983979A (zh) | 2018-06-27 | 2022-09-02 | 比奥克斯塞尔医疗股份有限公司 | 含右美托咪定的膜制剂及其制造方法 |
KR20220049526A (ko) | 2019-07-19 | 2022-04-21 | 바이오엑셀 테라퓨틱스 인코포레이티드 | 비-진정성 덱스메데토미딘 치료 양생법 |
US11806334B1 (en) | 2023-01-12 | 2023-11-07 | Bioxcel Therapeutics, Inc. | Non-sedating dexmedetomidine treatment regimens |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2515035A1 (fr) * | 1981-10-26 | 1983-04-29 | Rhone Poulenc Sante | Nouvelle forme galenique solide pour administration par voie orale et son procede de fabrication |
FR2561916B1 (fr) * | 1984-03-30 | 1987-12-11 | Lafon Labor | Forme galenique pour administration orale et son procede de preparation par lyophilisation d'une emission huile dans eau |
WO1985005029A1 (en) * | 1984-05-09 | 1985-11-21 | Medaphore Inc. | Oral insulin and a method of making the same |
JPS62265234A (ja) * | 1986-05-14 | 1987-11-18 | Showa Yakuhin Kako Kk | 苦味抑制製剤組成物 |
NL193682C (nl) * | 1987-05-14 | 2000-07-04 | Glaxo Group Ltd | Beklede cefuroximaxetilsamenstelling. |
EP0409432A3 (en) * | 1989-07-20 | 1991-12-11 | Warner-Lambert Company | Confectionery delivery system |
US5039540A (en) * | 1989-08-14 | 1991-08-13 | Neophore Technologies, Inc. | Freeze dry composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs |
US5079018A (en) * | 1989-08-14 | 1992-01-07 | Neophore Technologies, Inc. | Freeze dry composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs |
CA2103443C (en) * | 1991-05-28 | 1998-12-22 | Robert P. Geyer | Chewable drug-delivery composition |
US5407921A (en) * | 1993-07-01 | 1995-04-18 | Kao Corporation | Method for suppressing bitter taste |
JP3776941B2 (ja) * | 1993-12-24 | 2006-05-24 | 塩野義製薬株式会社 | 味覚の改善された顆粒剤及びその製造方法 |
JPH07267850A (ja) * | 1994-03-28 | 1995-10-17 | Eisai Co Ltd | 不快味を防止した医薬組成物及びその製造方法 |
JP3325116B2 (ja) * | 1994-04-28 | 2002-09-17 | 花王株式会社 | 苦味低減化剤、その製造法、苦味低減化法、そして苦味低減化組成物 |
US5567439A (en) * | 1994-06-14 | 1996-10-22 | Fuisz Technologies Ltd. | Delivery of controlled-release systems(s) |
GB9421836D0 (en) * | 1994-10-28 | 1994-12-14 | Scherer Corp R P | Process for preparing solid pharmaceutical dosage forms of hydrophobic substances |
CA2134611C (en) * | 1994-10-28 | 2002-12-24 | Richard John Yarwood | Process for preparing solid pharmaceutical dosage forms |
-
1997
- 1997-02-12 GB GBGB9702799.9A patent/GB9702799D0/en active Pending
-
1998
- 1998-02-12 ES ES98904265T patent/ES2178154T3/es not_active Expired - Lifetime
- 1998-02-12 PT PT98904265T patent/PT973506E/pt unknown
- 1998-02-12 EP EP98904265A patent/EP0973506B1/en not_active Expired - Lifetime
- 1998-02-12 DK DK98904265T patent/DK0973506T3/da active
- 1998-02-12 CA CA002278785A patent/CA2278785C/en not_active Expired - Lifetime
- 1998-02-12 AT AT98904265T patent/ATE219664T1/de active
- 1998-02-12 AU AU62212/98A patent/AU6221298A/en not_active Abandoned
- 1998-02-12 BR BRPI9808641-3A patent/BR9808641B1/pt not_active IP Right Cessation
- 1998-02-12 JP JP53546598A patent/JP4763105B2/ja not_active Expired - Lifetime
- 1998-02-12 DE DE69806236T patent/DE69806236T2/de not_active Expired - Lifetime
- 1998-02-12 WO PCT/GB1998/000425 patent/WO1998035656A1/en active IP Right Grant
-
1999
- 1999-08-10 US US09/387,702 patent/US6156339A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JP2001511800A (ja) | 2001-08-14 |
EP0973506B1 (en) | 2002-06-26 |
US6156339A (en) | 2000-12-05 |
PT973506E (pt) | 2002-10-31 |
AU6221298A (en) | 1998-09-08 |
GB9702799D0 (en) | 1997-04-02 |
DE69806236T2 (de) | 2003-02-20 |
BR9808641B1 (pt) | 2009-05-05 |
BR9808641A (pt) | 2000-05-23 |
CA2278785A1 (en) | 1998-08-20 |
ATE219664T1 (de) | 2002-07-15 |
CA2278785C (en) | 2005-08-09 |
JP4763105B2 (ja) | 2011-08-31 |
DK0973506T3 (da) | 2002-07-22 |
WO1998035656A1 (en) | 1998-08-20 |
DE69806236D1 (de) | 2002-08-01 |
EP0973506A1 (en) | 2000-01-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2178154T3 (es) | Proceso de preparacion de formas solidas de dosificacion farmaceutica. | |
ES2153498T3 (es) | Proceso para preparar formas de dosificacion farmaceutica solidas. | |
MX9602515A (es) | Procedimiento para preparar formas de dosis farmaceuticas de substancias hidrofobicas. | |
MX9602683A (es) | Compuestos de 6-dimetilaminometil-1-fenil-ciclohexano como substancias farmaceuticamente activas. | |
ATE554750T1 (de) | Hydrophobe pharmazeutische wirkstoffe enthaltende zubereitungen | |
IL153011A0 (en) | Sustained release pharmaceutical compositions for parenteral administration of hydrophilic compounds | |
YU96602A (sh) | Postupak za spravljanje smeše | |
CA2366702A1 (en) | Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents | |
MA26508A1 (fr) | Formulations pharmaceutiques contenant du variconazole, et procede pour leur preparation. | |
FI20011852A (fi) | Menetelmä fluoksetiinia tai sen happoadditiosuolaa sisältävän dispergoituvan tabletin valmistamiseksi | |
KR970703131A (ko) | 소수성 활성물질과 발포제를 포함하는 제약학적 조성물과 이의 준비공정(pharmaceutical preparation with a hydrophobic active substance and an effer vescent system, and process for preparing said preparation) | |
HUP0004362A2 (hu) | Karbamazepint vagy származékait tartalmazó parenterális készítmények | |
FR2765223B1 (fr) | Nouveaux derives tricycliques du benzimidazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
EP0781135A4 (en) | FORMULATIONS CONTAINING CODEINE | |
IE890275L (en) | Pharmaceutical composition for 4-aroylimidazol-2-ones | |
IT1272762B (it) | Derivati benz/e/indenici farmaceuticamente attivi,procedimento per la loro preparazione e relative composizioni farmaceutiche | |
IT1257000B (it) | Derivati dell'eserolina ad attivita` anticolinesterasica, procedimento per la loro preparazione e composizioni farmaceutiche cheli contengono. | |
RU93049678A (ru) | Устойчивый водорастворимый ветеринарный препарат и способ его получения |